This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

NACompletedINTERVENTIONAL

Enrollment

459

Participants

Timeline

Start Date

January 8, 2008

Primary Completion Date

October 26, 2015

Study Completion Date

November 2, 2015

Conditions

Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Interventions

DEVICE

Coaptite®

Calcium hydroxylapatite particles suspended in an aqueous based gel carrier

Trial Locations (20)

Wetumpka

Surprise

Encinitas

Los Angeles

Oceanside

Orange

Templeton

Celebration

Orlando

St. Petersburg

Berwyn

Evanston

Overland Park

Grand Rapids

St Louis

Rochester

Akron

Houston

Temple

Mountlake Terrace

All Listed Sponsors

lead

Merz North America, Inc.

INDUSTRY

NCT00996489 - This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence | Biotech Hunter | Biotech Hunter